Skip to main content
Clinical Trials/NCT01825694
NCT01825694
Completed
Not Applicable

An Integrated Treatment for Comorbid PTSD and Substance Abuse in Adolescents

University of California, Los Angeles1 site in 1 country117 target enrollmentApril 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Substance Abuse
Sponsor
University of California, Los Angeles
Enrollment
117
Locations
1
Primary Endpoint
Urine Toxicology Screen (UTS)
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This study plans to develop an integrated treatment for comorbid post-traumatic stress disorder (PTSD) and substance abuse (SA) in adolescents. The investigators aim to develop a treatment approach that is community-friendly, well-tolerated, and deliverable by substance abuse counselors (SAC) in outpatient settings. The proposed Trauma-Focused Substance Abuse Treatment (TFSAT) aims to reduce PTSD symptoms and substance use and build coping skills. The investigators propose to adapt an evidence-based trauma program, Cognitive-Behavioral Intervention for Trauma in Schools (CBITS), for adolescent substance abusers (ASAbusers); to assess the acceptability and feasibility of the integrated approach; and to pilot test the new program against standard care.

The investigators hypothesize that the intervention group, compared to the control group, will reduce substance use and symptoms for traumatic stress.

Registry
clinicaltrials.gov
Start Date
April 2013
End Date
May 2015
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Between ages of 13 \& 19;
  • meeting DSM IV criteria for substance abuse/dependence and PTSD;
  • previously enrolled at recruitment site for at least 2 weeks;
  • parent/guardian provides permission for minors to participate.

Exclusion Criteria

  • Not within the specified age range;
  • presence of organic brain damage;
  • inability to understand enrollment forms (e.g. Informed Assent/Consent Form)
  • Inclusion Criteria: Parents/Guardians
  • Age 18 or above;
  • parents/guardians of youth who meets inclusion criteria.
  • Exclusion Criteria: Parents/Guardians
  • presence of organic brain damage.

Outcomes

Primary Outcomes

Urine Toxicology Screen (UTS)

Time Frame: Participants will be followed for an expected average of 12 weeks.

Urine samples will be collected twice per week at the treatment site to ensure validity of self-reports.

Child PTSD Symptom Scale (CPSS)

Time Frame: Change from Baseline in Child PTSD Symptom Scale at 8 weeks and change from Baseline in Child PTSD Symptom Scale at 12 weeks.

The CPSS will assess for severity of traumatic stress symptoms.

Timeline Follow-back (TFLB) Assessment of Substance Use

Time Frame: Participants will be followed for an expected average of 12 weeks.

The TLFB uses a blank calendar form and a series of questions to cue recall of alcohol and drug (AOD) use. The investigators will use the TLFB interview technique to assess AOD use weekly.

Secondary Outcomes

  • Child Post-Trauma Attitudes Scale (C-PTAS)(Baseline & 8 weeks & 3 months)
  • Strengths & Difficulties Questionnaire (SDQ)(Baseline & 8 weeks & 3 months)

Study Sites (1)

Loading locations...

Similar Trials